Effect of 1-year cholecalciferol supplementation from early post-transplant preiod in kidney transplant recipients: a randomized controlled trial
Not Applicable
- Conditions
- kidney transplantation
- Registration Number
- JPRN-UMIN000020597
- Lead Sponsor
- agoya Daini Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 193
Inclusion Criteria
Not provided
Exclusion Criteria
1. On supplementation with native vitamin D (i.e., cholecalciferiol or ergocaliferol) 2. Corrected calcium >= 11.0 mg/dL 3. Patients judged to be inappropriate by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in estimated glomerular filtration rate at 1 year after KTx with adjustment for baseline values
- Secondary Outcome Measures
Name Time Method 1. Urinary kidney injury biomarkers (i.e., L-FABP and/or urinary protein/creatinine) at 6 months and 12 months after KTx 2. Pathophysiological findings on transplanted kidney at 12 months after KTx 3. Body compositions at 6 months and 12 months after transplantation 4. Bone metabolic markers and bone mineral density at 12 months after KTx 5. Prevalence of the development of hypercalcemia (corrected serum calcium>=11mg/dL) 6. Hospitalization-requiring infection-free survival